# Noriyuki Yamada

> Noriyuki Yamada is a venture - series unknown investor at SBI Shinsei Corporate Investment backing Biopharma. See 1 investments, check sizes, portfolio and…

- Type: Angel Investor
- Fund: [SBI Shinsei Corporate Investment](https://shizune.co/investors/profile/sbi-shinsei-corporate-investment)
- Total investments: 1
- Last investment: Sep 2026
- Lead investor: 0%
- Last updated: Oct 2026

Noriyuki Yamada is a Senior Director at SBI Shinsei Corporate Investment

## Contacts

5 contacts available for Noriyuki Yamada: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/noriyuki-yamada?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AOI Biosciences | AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses. | $3.2M | Venture - Series Unknown | Sep 14, 2026 | https://www.aoibio.com |

1 of 1 investments shown.

## Co-investors
- [BIG Impact](https://shizune.co/investors/profile/big-impact-ec83) — VC Fund, 1 deal together
- [Chushin Venture Capital](https://shizune.co/investors/profile/chushin-venture-capital-6384) — VC Fund, 1 deal together
- [GoAhead Ventures](https://shizune.co/investors/profile/goahead-ventures) — VC Fund, 1 deal together
- [i-nest capital](https://shizune.co/investors/profile/i-nest-capital) — VC Fund, 1 deal together
- [Nippon Venture Capital](https://shizune.co/investors/profile/nippon-venture-capital) — VC Fund, 1 deal together
- [SBI Okasan Alternative Investment Co](https://shizune.co/investors/profile/okasan-capital-partners) — VC Fund, 1 deal together

## About SBI Shinsei Corporate Investment

VC Fund · Tokyo, Japan

SBI Shinsei Corporate Investment is an investment company that manages funds with disciplined and rational judgment in venture investments and buyout investments.

2 contacts available at SBI Shinsei Corporate Investment.

| Name | Title | Profile |
| --- | --- | --- |
| Kenji Uesaka | President & CEO | https://shizune.co/investors/profile/kenji-uesaka |
| Noriyuki Yamada | Senior Director | https://shizune.co/investors/profile/noriyuki-yamada |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

## FAQ

### What does Noriyuki Yamada invest in?

Noriyuki Yamada invests primarily in Biopharma and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Noriyuki Yamada?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Noriyuki Yamada last invest?

The most recent investment recorded for Noriyuki Yamada closed in Sep 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
